FRIDAY, Nov. 1, 2024 -- Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis -- a potentially lethal stiffening of tissue that,...
Vous n'êtes pas connecté
A team at Nagoya University Graduate School of Medicine has found that the enzyme protein kinase N (PKN) plays a role in cardiac fibrosis linked to heart failure. In mice models, deleting PKN reduced ventricular dysfunction and tissue buildup. These findings suggest that anti-PKN therapies could potentially protect against heart failure. The research was published in Nature Communications.
FRIDAY, Nov. 1, 2024 -- Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis -- a potentially lethal stiffening of tissue that,...
FRIDAY, Nov. 1, 2024 -- Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis -- a potentially lethal stiffening of tissue that,...
Scientists at the Gladstone Institutes have discovered how immune cells in the heart trigger scarring, a process known as fibrosis, which plays a key...
A glaucoma medication, methazolamide, has been found to reduce the accumulation of tau protein in zebrafish and mice, offering potential hope for...
Researchers at The Ohio State University have made a breakthrough in understanding why certain heart rhythm disorders, known as calmodulinopathies,...
Dr. Kelly and her colleagues synthesized a panel of PDCs aiming at the precise treatment of pulmonary fibrosis, where nintedanib - a potent kinase...
A study by researchers at the University of Wisconsin School of Medicine and Public Health, led by Professor Dudley Lamming, has found that reducing...
A new study from Karolinska Institutet shows that heart failure mortality has decreased in Sweden over the last 20 years. The study has been published...
A groundbreaking study, GUARDIAN, is exploring the potential of DNA analysis for newborn screening. (!--ref1--) Early findings suggest that genome...